CNSA Vascular Access Devices: Evidence Based Clinical Practice Guidelines: Online launch 3 November!
Posted by Kerrie Curtis on 28 October 2021
Vascular access devices are lifelines for patients with cancer for the administration of prescribed therapies and supportive care. Evidence-based management is key in the prevention of vascular access complications and premature removal. The revised Cancer Nurses Society of Australia (CNSA) Vascular Access Devices: Evidence Based Clinical Practice Guidelines detail the latest evidence and recommendations for patients with cancer with peripheral intravenous cannulas and central venous ac...
|Posted in:peripheral intravenous cathetercentral vascular access deviceseducationpatient safetyguidelinesevidence-based practice|
Posted by Lizzy Ostwald on 26 October 2021
Aseptic non-touch technique (ANTT®) Aseptic non-touch technique (ANTT®), a framework developed by Rowley in the 1990's, focuses on the identification and prevention of microbial contamination of aseptic parts or sites during clinical procedures. ANTT® ensures aseptic parts or sites are not touched - either directly or indirectly, ensuring sterility during procedures that can cause significant patient harm if performed incorrectly1. Since its conception, ANTT® has bee...
|Posted in:peripheral intravenous cathetercentral vascular access devicesvascular access devices|
Posted by Lizzy Ostwald on 7 October 2021
What is an umbilical catheter? Umbilical catheterisation is a procedure performed by highly skilled neonatal clinicians shorty after birth in premature or critically unwell neonates1. The procedure allows for central venous and arterial access, enabling administration of medications and fluids, painless blood drawing, and continuous blood pressure monitoring2,3. Umbilical venous catheters are inserted through the umbilical vein and travel through the ductus venosus, through to the inferior ...
|Posted in:central vascular access devicesumbilical catheters|
3M Health Care Academy - The 2021 INS Infusion Therapy Standards of Practice: Focusing on Catheter Securement: Science and best practices
Posted on 29 September 2021
|Posted in:dressingsIV managementsecurementvascular access devicesguidelines|
Posted by Lizzy Ostwald on 24 September 2021
The insertion of a vascular access device (VAD) is one of the most common invasive procedures performed in the hospital setting, however a number of factors across adult and paediatric populations including age, weight extremes, comorbidities, previous difficult intravenous access, and site selection for current VAD can significantly impact overall insertion success and maintenance of a device.1,2 Dedicated vascular access teams are made up of competent clinicians trained to maxi...
|Posted in:insertionvascular access devicesspecialist teams|
Posted by Lizzy Ostwald and Gillian Ray-Barruel on 23 September 2021
Introduced in the 1990s, needleless connectors have become an essential component of 21st century medical care, as they have removed the inherent needle stick injury risk associated with older needle-based connectors.1 Used on both central and peripheral vascular access devices, they allow for the safer administration of medication, fluid and blood.2 However, needleless connectors carry a significantly increased risk of bloodstream infection. If the injection site has not been properly ...
|Posted in:infection preventionneedleless connectorcatheter-associated bloodstream infection|
Posted by Lizzy Ostwald on 21 September 2021
Central venous access devices (CVADs) are an essential component of contemporary medical care, allowing for incompatible medications to be administered simultaneously and reduce the need for peripheral vascular access, particularly for critically ill or oncology patients.1 However, CVADs can entail significant risk. Bloodstream infection is the most detrimental consequence of inadequate CVAD management, presenting a significant burden to the patient, staff and economy of a hospital, especial...
|Posted in:central vascular access devicescatheter-associated bloodstream infection|
Posted by Lizzy Ostwald on 20 September 2021
Peripheral intravenous cannulation (PIVC) is commonplace in the neonatal setting, particularly in premature and critically unwell neonates who are unable to regulate homeostatic balance.1 Cannulation of a neonate can be difficult, given the significantly smaller venous anatomy and compromised skin integrity which can lead to localised toxicity and inflammation.2 Failure rates can be high, with 95% of PIVCs being removed due to complications including occlusion, leaking and extravasation inju...
|Posted in:peripheral intravenous catheterassessmentneonate|
Posted by Lizzy Ostwald on 19 August 2021
Of the 11 million Australians accessing care in a hospital each year, an estimated 7.7 million will receive a peripheral intravenous catheter (PIVC), also called a cannula, meaning this procedure is commonplace, particularly in the emergency department.(1) Although this is such a common procedure, first-attempt failure rates are high, with an estimated 40% failure rate in adults and 65% in the paediatric population.(1) All clinicians who are cannulation competent must be abl...
|Posted in:peripheral intravenous cathetercannulapatient experienceIV insertionvessel health|
Posted by Gillian Ray-Barruel on 19 August 2021
Did you know that certain catheter-to-vein (CVR) ratios can have twice the risk of thrombosis in patients with cancer? Dr Rebecca Sharp from the University of South Australia (UniSA) and Australian Vascular Access Society has published a study in BMJ Open that analysed the outcomes of more than 2400 patients from 4 hospitals in Australia and New Zealand who received a peripherally inserted central catheter (PICC). The study found that up to 6% of patients with cancer who had received chemo...
|Posted in:catheter failurecentral vascular access devicesPICCultrasoundevidence-based practice|